<?xml version="1.0" encoding="UTF-8"?>
<p id="par0140">Treatment usually relies on supportive measures and the aforementioned anti-viral therapies. In early parts of this stage (IIa), the use of corticosteroids in patients with COVID-19 may be avoided. While in stage IIb, the use of anti-inflammatory treatment may be permitted, indeed, the presence of hypoxia may indicate the high probability of unfavorable systemic evolution [
 <xref rid="bib0025" ref-type="bibr">5</xref>,
 <xref rid="bib0040" ref-type="bibr">8</xref>].
</p>
